AAAAAA

   
Results: 1-12 |
Results: 12
Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?
Authors: Langman, MJS
Citation: Mjs. Langman, Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?, PHARMA D S, 10(1), 2001, pp. 13-19
Heparin therapy for ulcerative colitis? Effects and mechanisms
Authors: Michell, NP Lalor, P Langman, MJS
Citation: Np. Michell et al., Heparin therapy for ulcerative colitis? Effects and mechanisms, EUR J GASTR, 13(4), 2001, pp. 449-456
Which PPI?
Authors: Langman, MJS
Citation: Mjs. Langman, Which PPI?, GUT, 49(2), 2001, pp. 309-310
Drug treatment of non-variceal upper gastrointestinal bleeding
Authors: Langman, MJS
Citation: Mjs. Langman, Drug treatment of non-variceal upper gastrointestinal bleeding, BEST PR RES, 14(3), 2000, pp. 357-364
Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database
Authors: Langman, MJS Cheng, KK Gilman, EA Lancashire, RJ
Citation: Mjs. Langman et al., Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database, BR MED J, 320(7250), 2000, pp. 1642-1646
Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs
Authors: Weil, J Langman, MJS Wainwright, P Lawson, DH Rawlins, M Logan, RFA Brown, TP Vessey, MP Murphy, M Colin-Jones, DG
Citation: J. Weil et al., Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs, GUT, 46(1), 2000, pp. 27-31
Oestrogen inactivation in the colon: analysis of the expression and regulation of 17 beta-hydroxysteroid dehydrogenase isozymes in normal colon and colonic cancer
Authors: English, MA Hughes, SV Kane, KF Langman, MJS Stewart, PM Hewison, M
Citation: Ma. English et al., Oestrogen inactivation in the colon: analysis of the expression and regulation of 17 beta-hydroxysteroid dehydrogenase isozymes in normal colon and colonic cancer, BR J CANC, 83(4), 2000, pp. 550-558
Epidemiology of non-steroidal anti-inflammatory drug damage to stomach andduodenum
Authors: Langman, MJS
Citation: Mjs. Langman, Epidemiology of non-steroidal anti-inflammatory drug damage to stomach andduodenum, ITAL J GAST, 31, 1999, pp. S2-S5
Risks of anti-inflammatory drug-associated damage
Authors: Langman, MJS
Citation: Mjs. Langman, Risks of anti-inflammatory drug-associated damage, INFLAMM RES, 48(5), 1999, pp. 236-238
Escherichia coli for ulcerative colitis
Authors: Langman, MJS Allan, RN
Citation: Mjs. Langman et Rn. Allan, Escherichia coli for ulcerative colitis, LANCET, 354(9194), 1999, pp. 2000-2001
Loss of estrogen inactivation in colonic cancer
Authors: English, MA Kane, KF Cruickshank, N Langman, MJS Stewart, PM Hewison, M
Citation: Ma. English et al., Loss of estrogen inactivation in colonic cancer, J CLIN END, 84(6), 1999, pp. 2080-2085
Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer
Authors: Langman, MJS Dunn, JA Whiting, JL Burton, A Hallissey, MT Fielding, JWL Kerr, DJ
Citation: Mjs. Langman et al., Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer, BR J CANC, 81(8), 1999, pp. 1356-1362
Risultati: 1-12 |